C. Lin, S. Franceschi, and G. M. Clifford, Human papillomavirus types from infection to cancer in the 579 anus, according to sex and HIV status: a systematic review and meta-analysis, Lancet Infect Dis, vol.580, pp.198-206, 2018.

A. K. Chaturvedi, E. A. Engels, R. M. Pfeiffer, B. Y. Hernandez, W. Xiao et al., , p.582

M. Sibug-saber, W. Cozen, L. Liu, C. F. Lynch, N. Wentzensen et al., , p.583

P. S. Rosenberg and M. L. Gillison, Human papillomavirus and rising oropharyngeal cancer incidence in 584 the United States, J Clin Oncol Off J Am Soc Clin Oncol, vol.29, pp.4294-301, 2011.

J. M. Walboomers, M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer et al., , p.586

C. J. Meijer and N. Muñoz, Human papillomavirus is a necessary cause of invasive cervical cancer 587 worldwide, J Pathol, vol.189, pp.12-21, 1999.

M. Schiffman, J. Doorbar, N. Wentzensen, S. De-sanjosé, C. Fakhry et al., Franceschi 589 S. Carcinogenic human papillomavirus infection, Nat Rev Dis Primer, vol.2, p.16086, 2016.

C. Woodman, S. I. Collins, and L. S. Young, The natural history of cervical HPV infection: unresolved 591 issues, Nat Rev Cancer, vol.7, pp.11-22, 2007.

J. Doorbar, W. Quint, L. Banks, I. G. Bravo, M. Stoler et al., The biology and life-593 cycle of human papillomaviruses, Vaccine, vol.30, pp.55-70, 2012.

N. Shulzhenko, H. Lyng, G. F. Sanson, and A. Morgun, Ménage à trois: an evolutionary interplay between 595 human papillomavirus, a tumor, and a woman, Trends Microbiol, vol.22, pp.345-53, 2014.

M. L. Tornesello, L. Buonaguro, P. Giorgi-rossi, and F. M. Buonaguro, Viral and cellular biomarkers in the 597 diagnosis of cervical intraepithelial neoplasia and cancer, BioMed Res Int, p.519619, 2013.

G. S. Ogilvie, D. Van-niekerk, M. Krajden, L. W. Smith, D. Cook et al., , p.599

M. , M. R. Gentile, L. Peacock, S. Stuart, G. Franco et al., Effect of Screening With 600

, Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia 601 at 48 Months: The HPV FOCAL Randomized Clinical Trial, JAMA, vol.320, pp.43-52, 2018.

J. Cuzick, L. Cadman, D. Mesher, J. Austin, L. Ashdown-barr et al., , p.603

D. and S. A. , Comparing the performance of six human papillomavirus tests in a screening 604 population, Br J Cancer, vol.108, pp.908-921, 2013.

E. Virtanen, I. Kalliala, T. Dyba, P. Nieminen, and E. Auvinen, Performance of mRNA-and DNA-based 606 high-risk human papillomavirus assays in detection of high-grade cervical lesions, Acta Obstet, p.607

G. Scand, , vol.96, pp.61-69, 2017.

D. A. Cook, L. W. Smith, J. Law, W. Mei, D. J. Van-niekerk et al., , p.609

G. S. Ogilvie, D. Jang, M. Chernesky, and M. Krajden, Aptima HPV Assay versus Hybrid Capture® 2 HPV 610 test for primary cervical cancer screening in the HPV FOCAL trial, J Clin Virol Off Publ Pan Am Soc, p.611

, Clin Virol, vol.87, pp.23-32, 2017.

Y. Ge, P. Christensen, E. Luna, D. Armylagos, J. Xu et al., Aptima Human, p.613

, Papillomavirus E6/E7 mRNA Test Results Strongly Associated With Risk for High-Grade Cervical 614

, Lesions in Follow-Up Biopsies, J Low Genit Tract Dis, vol.22, 2018.

L. De-thurah, J. Bonde, J. Lam, and M. Rebolj, Concordant testing results between various human 616 papillomavirus assays in primary cervical cancer screening: systematic review, Clin Microbiol, p.617

, Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.29-36, 2018.

D. Hawkes, J. Brotherton, and M. Saville, Not all HPV nucleic acid tests are equal: only those 619 calibrated to detect high grade lesions matter for cervical screening, Clin Microbiol Infect Off, vol.620

, Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.436-443, 2018.

L. De-thurah, J. Bonde, J. Lam, and M. Rebolj, Not all HPV nucleic acid tests are equal: only those 622 calibrated to detect high grade lesions matter for cervical screening: Response to "Concordant 623 testing results between various human papillomavirus assays in primary cervical cancer 624 screening: systematic review" by de Thurah, Bonde, Uyen, Lam and Rebolj, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.24, pp.438-447, 2017.

I. Heard, K. Cuschieri, D. T. Geraets, W. Quint, and M. Arbyn, , p.627

H. Papillocheck, Screening assay using the VALGENT framework, J Clin Virol Off Publ Pan Am, vol.628

, Soc Clin Virol, vol.81, pp.6-11, 2016.

Z. Chen, M. Schiffman, R. Herrero, R. Desalle, K. Anastos et al., , p.630

A. W. Hsing and R. D. Burk, Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete 631

, Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70, vol.8, p.72565, 2013.

M. Kearse, R. Moir, A. Wilson, S. Stones-havas, M. Cheung et al., , p.633

S. Markowitz, C. Duran, T. Thierer, B. Ashton, P. Meintjes et al., Geneious Basic: an 634 integrated and extendable desktop software platform for the organization and analysis of 635 sequence data, Bioinforma Oxf Engl, vol.28, pp.1647-1656, 2012.

Z. Zheng and C. C. Baker, Papillomavirus genome structure, expression, and post-transcriptional 637 regulation, Front Biosci J Virtual Libr, vol.11, pp.2286-302, 2006.

X. Wang, C. Meyers, H. Wang, L. T. Chow, and Z. Zheng, Construction of a full transcription map of 639 human papillomavirus type 18 during productive viral infection, J Virol, vol.85, p.26, 2011.

N. Wentzensen, R. Ridder, R. Klaes, S. Vinokurova, U. Schaefer et al., Characterization 641 of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions

, Oncogene, vol.21, pp.419-445, 2002.

K. Tang, B. Alaei-mahabadi, T. Samuelsson, M. Lindh, and E. Larsson, The landscape of viral 644 expression and host gene fusion and adaptation in human cancer, Nat Commun, vol.4, p.2513, 2013.

M. Peter, C. Rosty, J. Couturier, F. Radvanyi, H. Teshima et al., MYC activation associated 646 with the integration of HPV DNA at the MYC locus in genital tumors, Oncogene, vol.25, p.93, 2006.

X. Lu, Q. Lin, M. Lin, P. Duan, L. Ye et al., Multiple-integrations of HPV16 649 genome and altered transcription of viral oncogenes and cellular genes are associated with the 650 development of cervical cancer, PloS One, vol.9, p.97588, 2014.

I. Kraus, C. Driesch, S. Vinokurova, E. Hovig, A. Schneider et al., The 652 majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences 653 of known or predicted genes, Cancer Res, vol.68, pp.2514-2536, 2008.

A. Dobin, C. A. Davis, F. Schlesinger, J. Drenkow, C. Zaleski et al., 655 STAR: ultrafast universal RNA-seq aligner, Bioinformatics, vol.29, pp.15-21, 2013.

J. Friedman, T. Hastie, and R. Tibshirani, Regularization Paths for Generalized Linear Models via 657

, Coordinate Descent. J Stat Softw, vol.33, pp.1-22, 2010.

V. Dalstein, S. Merlin, C. Bali, M. Saunier, R. Dachez et al., , p.659

, PapilloCheck test, a new commercial DNA chip for detection and genotyping of human 660 papillomavirus, J Virol Methods, vol.156, pp.77-83, 2009.

S. J. Klug, A. Molijn, B. Schopp, B. Holz, A. Iftner et al., , p.662

C. Munk and T. Iftner, Comparison of the performance of different HPV genotyping methods for 663 detecting genital HPV types, J Med Virol, vol.80, pp.1264-74, 2008.

J. Cuzick, A. Szarewski, H. Cubie, G. Hulman, H. Kitchener et al., , vol.665

G. Edwards, R. Brooks, C. Desai, M. Gie, C. Ho et al., Management of 666 (average values), (B) Viral transcripts E6 & E7 (average values). The relative abundance (y-axis, log 734 scale) is calculated in comparison to the higher expression value of the dataset, p.735

, JPEG, vol.736, issue.2, p.2233

, Supplemental Figure 2: Evaluation of transport medium for RNA conservation: RNA integrity at D0, vol.2, p.738

D. D7, Bioanalyzer gel-like visualization of RNA profiles, showing 18S and 28S rRNA 739 populations (two distinct bands) as a marker of RNA integrity

, Supplemental Figure 3: Positive Predictive Value (PPV) of HPV RNA-Seq vs histology (in blue) and of 741 cytology vs histology (in red) function of the prevalence of HSIL in the population (P HSIL), p.743